The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
内卷堪比PD-1。 明星大单品司美格鲁肽正迎来越来越多的中国竞争者。 日前,又一款GLP-1(胰高血糖素样肽-1)类药物在国内商业化上市。2月11日 ...
Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.
BRP, identified through peptide prediction, may revolutionize weight loss treatment, offering efficacy without the ...
From there, the researchers tested 100 peptides they knew or suspected could affect the brain’s hunger drive (including GLP-1 for comparison). And ultimately, they identified one molecule that ...
10 天
Discover Magazine on MSNNew Molecule Competes with Ozempic, Showing Fewer Side EffectsA naturally occurring molecule that works as effectively as other semaglutide-based drugs — without the common side effects — ...
MolecuLern identified BLX-7006 as a novel small molecule capable of allosterically modulating GLP-1 receptor activity. Unlike many oral small-molecule GLP-1 therapies being developed—whose ...
You may soon be able to eat your Ozempic … sort of. GLP-1 supplements are booming, promising to deliver similar benefits to Ozempic and Wegovy without the pricey injections. The latest contender ...
GLP-1 drugs, originally for type 2 diabetes, are increasingly used for weight loss, but they can worsen eating disorders. Rapid weight loss from these drugs can reinforce harmful eating behaviors ...
10 天on MSN
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果